- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Celcuity (NASDAQ:CELC), Quotes and News Summary
Celcuity (NASDAQ: CELC)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-08 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.510 | -0.470 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Celcuity Questions & Answers
You can purchase shares of Celcuity (NASDAQ: CELC) through any online brokerage.
Other companies in Celcuity’s space includes: Graphite Bio (NASDAQ:GRPH), Immuneering (NASDAQ:IMRX), Atossa Therapeutics (NASDAQ:ATOS), Longeveron (NASDAQ:LGVN) and Akouos (NASDAQ:AKUS).
The latest price target for Celcuity (NASDAQ: CELC) was reported by Needham on Tuesday, May 17, 2022. The analyst firm set a price target for 25.00 expecting CELC to rise to within 12 months (a possible 177.16% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Celcuity (NASDAQ: CELC) is $9.02 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Celcuity.
Celcuity’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Celcuity.
Celcuity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.